ArticleAnnals of medicine2026
Evaluating the prognostic value of admission IL-8 and sST2 as biomarkers of early myocardial injury in severe community-acquired pneumonia.
Article in Annals of medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMyocardial injury in severe community-acquired pneumonia (SCAP) is often under-recognized, and interpretation of high-sensitivity cardiac troponin I (hs-cTnI) may be complicated by renal dysfunction and critical illness. We evaluated whether admission interleukin-8 (IL-8) and soluble suppression of tumorigenicity 2 (sST2) could support early risk stratification of guideline-consistent myocardial injury in patients with SCAP.
methodsIn this prospective cohort of 146 patients with SCAP, guideline-consistent myocardial injury was defined as hs-cTnI elevation above the assay-specific 99th percentile upper reference limit. Admission IL-8, sST2, and their combination were assessed using receiver operating characteristic curve analysis and 10-fold cross-validation. Fixed and estimated glomerular filtration rate (eGFR)-stratified hs-cTnI thresholds were compared in an exploratory analysis. An exploratory subgroup analysis was performed among patients with CURB-65 ≤ 1.
resultsThe median age was 71 years; 91 patients (62.3%) were male and 55 (37.7%) were female. Myocardial injury occurred in 88 patients (60.3%). The IL-8 + sST2 model showed good discrimination for myocardial injury, with an AUC of 0.825 (95% CI: 0.751-0.895) and an internally cross-validated AUC of 0.812. Admission IL-8 showed stronger individual discrimination than sST2. eGFR-stratified hs-cTnI thresholds did not reduce discordant hs-cTnI elevations in this cohort, likely because few patients had moderate-to-severe renal dysfunction. Among patients with CURB-65 ≤ 1 (
conclusionsAdmission IL-8 was associated with guideline-consistent myocardial injury in patients with SCAP, whereas sST2 showed weaker individual discrimination. The combined model had numerically higher discrimination than IL-8 alone, but the incremental contribution of sST2 remains uncertain. These findings represent an initial evaluation and require external validation before clinical implementation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.